7467 related articles for article (PubMed ID: 2318134)
1. [Recombinant tumor necrosis factor promotes the formation of hematogenic metastases to the lungs of C57Bl/6 mice].
Kudriavets IuI; Didkovskaia LP
Eksp Onkol; 1990; 12(2):47-50. PubMed ID: 2318134
[TBL] [Abstract][Full Text] [Related]
2. [Modifying effects of recombinant tumor necrosis factor on the metastatic potential of tumor cells].
Kudriavets IuI
Eksp Onkol; 1990; 12(1):43-7. PubMed ID: 2298142
[TBL] [Abstract][Full Text] [Related]
3. Reductive effect of lonazolac on lung metastasis formation in mice.
Mamytbeková A; Hájícek J; Grimová J; Rezábek K
Neoplasma; 1990; 37(3):349-55. PubMed ID: 2370919
[TBL] [Abstract][Full Text] [Related]
4. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin promotes lung colony formation in the mouse by B16 melanoma cells spheroids.
Coucke P; De Pauw-Gillet MC; De Leval L; Noel A; Bassleer R; Foidart JM
In Vivo; 1992; 6(5):481-6. PubMed ID: 1457739
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
Giavazzi R; Garofalo A; Bani MR; Abbate M; Ghezzi P; Boraschi D; Mantovani A; Dejana E
Cancer Res; 1990 Aug; 50(15):4771-5. PubMed ID: 2196116
[TBL] [Abstract][Full Text] [Related]
7. Effect of blocking TNF on IL-6 levels and metastasis in a B16-BL6 melanoma/mouse model.
Cubillos S; Scallon B; Feldmann M; Taylor P
Anticancer Res; 1997; 17(3C):2207-11. PubMed ID: 9216689
[TBL] [Abstract][Full Text] [Related]
8. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.
Okahara H; Yagita H; Miyake K; Okumura K
Cancer Res; 1994 Jun; 54(12):3233-6. PubMed ID: 7515767
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of tumor metastasis by platelet-activating factor.
Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
[TBL] [Abstract][Full Text] [Related]
10. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
Pearlstein E; Ambrogio C; Karpatkin S
Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
14. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis.
Wang HH; McIntosh AR; Hasinoff BB; Rector ES; Ahmed N; Nance DM; Orr FW
Cancer Res; 2000 Oct; 60(20):5862-9. PubMed ID: 11059784
[TBL] [Abstract][Full Text] [Related]
15. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6.
Mckenzie RC; Park ES; Brown WR; Shivji GS; Sauder DN
Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):74-9. PubMed ID: 8043388
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.
Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M
Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825
[TBL] [Abstract][Full Text] [Related]
17. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
[TBL] [Abstract][Full Text] [Related]
18. Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Jun; 6(2):185-97. PubMed ID: 17548797
[TBL] [Abstract][Full Text] [Related]
19. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells.
Nannmark U; Hokland ME; Agger R; Christiansen M; Kjaergaard J; Goldfarb RH; Bagge U; Unger M; Johansson BR; Albertsson PA; Basse PH
In Vivo; 2000; 14(5):651-8. PubMed ID: 11125549
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
Winkelhake JL; Stampfl S; Zimmerman RJ
Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
